News

Under the agreement, Mayo Clinic will become a participant in The Global Prevention Network, a select group of pre-eminent healthcare institutions with recognized research, preventive services and executive

The lawsuit was filed in response to an abbreviated new drug application (ANDA) filed by Mylan seeking the FDA approval to market and sell generic versions of Shire’s

Carvedilol phosphate extended release capsules (Coreg CR) was launched by GlaxoSmithKline in 2007 and is approved for use in treating three cardiovascular conditions: high blood pressure, also known

The fund will support biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas, in particular in neurodegenerative diseases, oncology and

Sepracor markets eszopiclone in the US under the brand name Lunesta. The lawsuit alleges infringement of Sepracor’s US patents. Due to the commencement of this litigation, abbreviated new

The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help

Mr Engle has broad management and financial background including six years at Dey LP, where he was the firm’s president and CEO. Mr Engle’s background also includes senior

According to Covidien, the OxiMax SPD feature enables the pulse oximeter to detect and alert clinicians of worrisome oxygen desaturation patterns, allowing them to make timely and more

Dalton Medicinal Chemistry will apply their proprietary insights to the design and synthesis of new classes of compounds against selected Riboswitch targets. BioRelix will advance these compounds with